Patent · US Active

N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use

US10961215B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Michael T. Rudd · Collegeville, US
Zhaoyang Meng · Ambler, US
Jenny Wai · Harleysville, US
David Jonathan Bennett · Watertown, US
Edward J. Brnardic · Lansdale, US
Nigel J. Liverton · Harleysville, US
Shawn J. Stachel · Perkasie, US
Yongxin Han · Kirkland, CA
Paul Tempest · Brookline, US
Jiuxiang Zhu · Shanghai, CN
Xuewang Xu · Shanghai, CN

Key dates

Filing date	Oct 9, 2017
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Nov 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

In its many embodiments, the present invention provides certain substituted N-aryl and N-heteroaryl piperidine compounds of the Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.